6108 — New Ray Medicine International Holding Balance Sheet

0.000.00%

Last trade - 00:00

Consumer DefensivesHighly SpeculativeMicro CapValue Trap

Market Cap
HK$41.13m
Enterprise Value
HK$6.17m
Revenue
HK$130.37m

Annual balance sheet for New Ray Medicine International Holding, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	HKAS	HKAS	HKAS	HKAS	HKAS
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	150	154	104	64.3	37.4
Net Total Accounts Receivable
Net Total Receivables	64.4	54	240	65.5	87.2
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	484	404	378	328	325
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	31.4	34.4	29.4	30.8	28.2
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	662	540	492	505	437
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	19.5	7.85	5.55	27.3	5.8
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Liabilities	29.5	14.2	11.3	34.3	12.3
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	633	526	480	471	424
Total Liabilities & Shareholders' Equity	662	540	492	505	437
Total Common Shares Outstanding